Shell Asset Management CO Eq Rx, Inc. Transaction History

Shell Asset Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$1.66 - $2.31 $566 - $787	-341 Reduced 1.54%	21,806 $48,000
Q2 2023 Jul 28, 2023	SELL	$1.61 - $1.96 $204 - $248	-127 Reduced 0.57%	22,147 $41,000
Q1 2023 May 15, 2023	SELL	$1.8 - $2.83 $138 - $217	-77 Reduced 0.34%	22,274 $43,000
Q4 2022 Feb 07, 2023	SELL	$2.05 - $5.5 $2,550 - $6,842	-1,244 Reduced 5.27%	22,351 $55,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $2,975 - $18,958	-3,165 Reduced 11.83%	23,595 $117,000
Q2 2022 Aug 09, 2022	BUY	$3.2 - $5.69 $85,632 - $152,264	26,760 New	26,760 $126,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.